NCT06104046

Brief Summary

observational cross sectional study for children with chronic kidney disease who on regular hemodialysis in assiut univeristy children hospital at dialysis unit, observe prevalence of serological seroconversion of hepatitis c virus and associated risk factors

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 21, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

October 26, 2023

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 27, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

October 27, 2023

Status Verified

October 1, 2023

Enrollment Period

1.2 years

First QC Date

October 21, 2023

Last Update Submit

October 25, 2023

Conditions

Hepatitis C Virus

Outcome Measures

Primary Outcomes (1)

  • Prevalence of Seroconversion of Hepatitis c Virus Among Children With CKD on Regular Hemodialysis

    determine prevalence and risk factors associated with seroconversion of hepatitis c in CKD children on regular hemodialysis

    Baseline

Eligibility Criteria

Age1 Year - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All patients on regular Hemodialysis for more than one month duration in Children AUH Dialysis Unit are enrolled in the study.

You may qualify if:

  • Age: from 1 year to 18 years
  • CKD children on regular hemodialysis for more than one month duration

You may not qualify if:

  • Age: less than 1 year and more than 18 years 2- CKD children who are not on regular hemodialysis and for less than one month duration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • El-Shabrawi MH, Kamal NM. Burden of pediatric hepatitis C. World J Gastroenterol. 2013 Nov 28;19(44):7880-8. doi: 10.3748/wjg.v19.i44.7880.

    PMID: 24307782BACKGROUND

  • Kosaraju K, Faujdar SS, Singh A, Prabhu R. Hepatitis viruses in heamodialysis patients: an added insult to injury? Hepat Res Treat. 2013;2013:860514. doi: 10.1155/2013/860514. Epub 2013 Mar 6.

    PMID: 23533739BACKGROUND

MeSH Terms

Conditions

Hepatitis C

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsHepatitis, Viral, HumanVirus DiseasesFlaviviridae InfectionsRNA Virus InfectionsHepatitisLiver DiseasesDigestive System Diseases

Central Study Contacts

Mahmoud Mohamed Zeawela

CONTACT

01098359166mahmoudz3wela777@gmail.com

Ghada Omar Elsedefy, professor

CONTACT

01111985154gelsedfy@med.aun.edu.eg

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
71515,Assiut

Study Record Dates

First Submitted

October 21, 2023

First Posted

October 27, 2023

Study Start

October 26, 2023

Primary Completion

December 31, 2024

Study Completion

March 31, 2025

Last Updated

October 27, 2023

Record last verified: 2023-10